{"id":"W4406870066","doi":"10.1200/jco.2025.43.4_suppl.534","title":"Characterization of the real-world first line (1L) use of single dose tremelimumab regular interval durvalumab (STRIDE), for treatment of unresectable hepatocellular carcinoma (uHCC), using two electronic medical record (EMR) databases.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Tremelimumab; Medicine; Durvalumab; Hepatocellular carcinoma; Internal medicine; Database; Oncology; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586889,0.0002313324,0.0003279646,0.001577572,0.0003778645,0.0009270859,0.0005435541,0.0004209956,0.001482913],"category_scores_gemma":[0.006497479,0.000267847,0.0004703673,0.001910075,0.0002362432,0.0008528258,0.0007786137,0.0005025915,0.0003570746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009432641,"about_ca_system_score_gemma":0.0009392698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008110166,"about_ca_topic_score_gemma":0.01494733,"domain_scores_codex":[0.9982646,0.0003370794,0.0003663397,0.0005628472,0.0003111876,0.0001579875],"domain_scores_gemma":[0.990739,0.001077496,0.00657123,0.0005916008,0.0006429304,0.0003777002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001836679,0.00004134744,0.9978511,0.00003984685,0.00007857726,0.00005765081,0.00009202203,0.00003333322,0.0001009109,0.00002908432,0.0003595106,0.001132955],"study_design_scores_gemma":[0.00002950454,0.0002132238,0.996833,0.00003734766,0.00006679201,0.0005564122,0.000350375,0.0004178899,0.0001497104,0.00002557384,0.001311605,0.000008645065],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879071,0.0003972336,0.0001581648,0.00007183907,0.000007480607,0.00007549045,0.01080382,0.000006519122,0.0005723396],"genre_scores_gemma":[0.9887955,0.0002272416,0.0003088809,0.00009796139,0.00002040689,0.0000959834,0.01026861,0.00000509119,0.0001803212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008110166,"threshold_uncertainty_score":0.01612592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2710967135358192,"score_gpt":0.4564556357622581,"score_spread":0.1853589222264389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}